Xylem, Inc.

As of October 31, 2025, Xylem, Inc. is considered expensive and overvalued with a P/E ratio of 35, despite a year-to-date return of 30.02%, as its valuation metrics suggest it trades at a premium compared to peers like Ingersoll Rand and Dover Corp.

As of October 31, 2025, Xylem, Inc. is considered expensive and overvalued, with a P/E ratio of 35 and a year-to-date return of 30.02%, despite outperforming the S&P 500 this year but lagging behind in longer-term returns.

As of October 17, 2025, Xylem, Inc. is considered overvalued with a valuation grade of expensive, reflected by a P/E ratio of 35 and weaker long-term performance compared to peers and the S&P 500, despite a strong year-to-date return of 25.76%.

As of October 17, 2025, Xylem, Inc. is considered overvalued with a P/E ratio of 35 and an EV to EBITDA of 20.21, despite a strong YTD return of 25.76%, as it lags behind the S&P 500 over longer periods.

As of October 17, 2025, Xylem, Inc. is considered overvalued with a P/E ratio of 35 and lower long-term performance compared to the S&P 500, despite a year-to-date return of 25.76%.

As of September 26, 2025, Xylem, Inc. has a bullish technical trend with strong indicators, outperforming the S&P 500 year-to-date with a 23.28% return, although it has lagged in longer-term performance.

As of September 26, 2025, Xylem, Inc. shows a bullish trend supported by strong MACD and Bollinger Bands indicators, despite some caution from the KST and OBV, with a year-to-date return of 23.28% outperforming the S&P 500.

As of September 12, 2025, Xylem, Inc. has a mildly bullish technical trend, supported by bullish indicators like the weekly MACD and moving averages, but tempered by bearish signals in the RSI and KST, while underperforming the S&P 500 over the past year and three years.

As of September 5, 2025, Xylem, Inc. is considered expensive and overvalued with a P/E ratio of 35, a Price to Book Value of 3.03, and an EV to EBITDA ratio of 20.21, while its performance has lagged behind the S&P 500, raising concerns about the justification of its current valuation.

As of April 29, 2025, Xylem, Inc. is considered overvalued with a P/E ratio of 35 and an EV to EBITDA of 20.21, despite a -9.50% stock return over the past year, indicating it is priced above its intrinsic value compared to peers.

As of June 17, 2025, Xylem, Inc. exhibits a neutral technical trend with mixed signals, showing a shift from mildly bearish to sideways, characterized by a bullish weekly MACD and a mildly bearish monthly MACD, indicating market uncertainty.

As of March 2022, the management team of Xylem, Inc. includes Markos Tambakeras (Independent Chairman), Patrick Decker (CEO), and several independent directors: Jeanne Beliveau-Dunn, Curtis Crawford, Robert Friel, Jorge Gomez, and Victoria Harker. They oversee the company's strategic direction and operations.

Xylem, Inc. is a water technology company specializing in engineered solutions for water and wastewater applications, with recent net sales of $2.066 billion and a market cap of $32.41 billion. Key metrics include a P/E ratio of 35.00 and a dividend yield of 112.93%.